BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34729556)

  • 21. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of age and sex on neuroinflammation following SARS-CoV-2 infection in a murine model.
    Krishna VD; Chang A; Korthas H; Var SR; Low WC; Li L; Cheeran MC
    bioRxiv; 2023 Aug; ():. PubMed ID: 37645925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe Acute Respiratory Syndrome Coronavirus 2 Infects and Damages the Mature and Immature Olfactory Sensory Neurons of Hamsters.
    Zhang AJ; Lee AC; Chu H; Chan JF; Fan Z; Li C; Liu F; Chen Y; Yuan S; Poon VK; Chan CC; Cai JP; Wu KL; Sridhar S; Chan YS; Yuen KY
    Clin Infect Dis; 2021 Jul; 73(2):e503-e512. PubMed ID: 32667973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
    Alam SB; Willows S; Kulka M; Sandhu JK
    Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system.
    Ostermann PN; Schaal H
    Rev Med Virol; 2023 Mar; 33(2):e2430. PubMed ID: 36790825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2.
    ElBini Dhouib I
    Drug Discov Ther; 2021 Jan; 14(6):262-272. PubMed ID: 33390561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
    Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
    J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
    Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
    Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2-associated T-cell infiltration in the central nervous system.
    Mohme M; Schultheiß C; Piffko A; Fitzek A; Paschold L; Thiele B; Püschel K; Glatzel M; Westphal M; Lamszus K; Matschke J; Binder M
    Clin Transl Immunology; 2024; 13(2):e1487. PubMed ID: 38304555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
    Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER
    Front Immunol; 2022; 13():1070379. PubMed ID: 36591311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampus.
    Bayat AH; Azimi H; Hassani Moghaddam M; Ebrahimi V; Fathi M; Vakili K; Mahmoudiasl GR; Forouzesh M; Boroujeni ME; Nariman Z; Abbaszadeh HA; Aryan A; Aliaghaei A; Abdollahifar MA
    Apoptosis; 2022 Dec; 27(11-12):852-868. PubMed ID: 35876935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
    Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
    mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
    Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse.
    Seehusen F; Clark JJ; Sharma P; Bentley EG; Kirby A; Subramaniam K; Wunderlin-Giuliani S; Hughes GL; Patterson EI; Michael BD; Owen A; Hiscox JA; Stewart JP; Kipar A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-specific biphasic alpha-synuclein response and alterations of interneurons in a COVID-19 hamster model.
    Schreiber CS; Wiesweg I; Stanelle-Bertram S; Beck S; Kouassi NM; Schaumburg B; Gabriel G; Richter F; Käufer C
    EBioMedicine; 2024 Jun; 105():105191. PubMed ID: 38865747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D Bioprinted Neural-Like Tissue as a Platform to Study Neurotropism of Mouse-Adapted SARS-CoV-2.
    de Melo BAG; Mundim MV; Lemes RMR; Cruz EM; Ribeiro TN; Santiago CF; da Fonsêca JHL; Benincasa JC; Stilhano RS; Mantovani N; Santana LC; Durães-Carvalho R; Diaz RS; Janini LMR; Maricato JT; Porcionatto MA
    Adv Biol (Weinh); 2022 Aug; 6(8):e2200002. PubMed ID: 35521969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin ameliorates spatial memory and motor deficits via preserving the integrity of cortical and hippocampal dendritic spine morphology in mice with neurotrauma.
    Lin XJ; Liu R; Li C; Yi X; Fu B; Walker MJ; Xu XM; Sun G; Lin CH
    Inflammopharmacology; 2020 Dec; 28(6):1553-1566. PubMed ID: 32959092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.